Company Filing History:
Years Active: 2016
Title: Innovations by Cheng-Chih Tsai in Heart Disease Treatment
Introduction
Cheng-Chih Tsai is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of medicine, particularly in the treatment and prevention of heart diseases. His innovative approach utilizes probiotic compositions to address critical health issues.
Latest Patents
Cheng-Chih Tsai holds a patent for a method aimed at treating or preventing heart diseases. This invention discloses a method that involves administering an effective amount of a probiotic composition to prevent myocardial cells from undergoing hypertrophy, fibrosis, and apoptosis. The probiotic composition includes LCR177 (BCRC910473), PA318 (BCRC910474), and BCRC14609. This patent represents a significant advancement in the field of cardiology.
Career Highlights
Cheng-Chih Tsai is associated with New Bellus Enterprises Co., Ltd., where he continues to develop innovative solutions for health-related challenges. His work has garnered attention for its potential impact on heart disease treatment.
Collaborations
Cheng-Chih Tsai collaborates with talented individuals such as Chih-Yang Huang and Hsueh-Fang Wang. Their combined expertise contributes to the advancement of research and development in their field.
Conclusion
Cheng-Chih Tsai's innovative methods for treating heart diseases highlight the importance of probiotics in medical science. His contributions are paving the way for new therapeutic approaches that could benefit many patients in the future.